dc.contributor.author | Almslati, Arwa Alsalmi M. | |
dc.date.accessioned | 2019-02-27T09:27:39Z | |
dc.date.available | 2019-02-27T09:27:39Z | |
dc.date.issued | 2018-04-14 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/591 | |
dc.description | SCID is a rare, potentially fatal syndrome of diverse genetic causes in which there is
combined absence of T-lymphocyte and B-lymphocyte function (and in many cases
also natural killer, or NK, lymphocyte function) and considered to be the most serious
of the primary immunodeficiencies. The different genetic causes of SCID vary with
respect to laboratory findings and patterns of inheritance.
There are about 13 genes that implicated in SCID which increase the susceptibility to
very serious infections. Luckily, effective treatments, such as stem cell
transplantation, exist that can cure the disorder. All types of primary
immunodeficiencies, not just SCID, stand to benefit from early diagnosis so early
identification of SCID can make possible life-saving intervention before infections
occu | en_US |
dc.description.abstract | Severe combined immunodeficiency (SCID)is a potentially fatal primary
immunodeficiency in which there is combined absence of T-lymphocyte and Blymphocyte
function. There are at least 13 different genetic defects that can cause
SCID. SCIDIs the most serious primary or congenital human immunodeficiency
disorder. Adenosine deaminase (ADA) deficiency is among the most common causes
of severe combined immunodeficiency and is autosomal recessively inherited through
mutations in the ADA gene, characterized by dysfunction of the T, B, and natural
killer (NK) cells (T-B-NK-SCID)
Mutations in the gene for Artemis (DCLRE1C) cause a rare form of autosomal
recessive radiosensitive SCID, which results in a T-B-NK+ phenotype.
General presentation occurs in infancy with lymphopenia, failure to thrive, diarrhea,
candidiasis, and Pneumocystis jiroveci pneumonia. In Artemis deficiencyPatients
with an Omenn syndrome phenotype have also been described. Even with supportive
therapies, patients with SCID will not survive without aHematopoietic stem cell
transplantation (HSCT). Patients transplanted before 3 months of age have a greater
survival while patients who are transplanted later and have suffered end organ
damage from infections have a much lower success rate. Overall, patients with T-BSCID
have less successful HSCT outcomes than patients with T-B+ SCID | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Two cases of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation and a novel missense mutation in DCLRE1C | en_US |
dc.type | Other | en_US |